175 related articles for article (PubMed ID: 36781038)
1. Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis.
Pamuk ON; Ali SM; Hasni S
Autoimmun Rev; 2023 Apr; 22(4):103297. PubMed ID: 36781038
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis.
Zhou EM; Shen H; Wang D; Xu W
PeerJ; 2024; 12():e17152. PubMed ID: 38666084
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Arthritis Res Ther; 2022 Sep; 24(1):213. PubMed ID: 36068638
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.
Hazzan R; Mukamel M; Yacobovich J; Yaniv I; Tamary H
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):657-9. PubMed ID: 16933242
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.
Altintas A; Ozel A; Okur N; Okur N; Cil T; Pasa S; Ayyildiz O
J Thromb Thrombolysis; 2007 Oct; 24(2):163-8. PubMed ID: 17436144
[TBL] [Abstract][Full Text] [Related]
6. Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children.
Song Y; Zhang Y; Li Z; Liu J; Xiao J; Song H
Ann Hematol; 2022 Jul; 101(7):1447-1456. PubMed ID: 35532821
[TBL] [Abstract][Full Text] [Related]
7. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of antinuclear antibody in patients with idiopathic thrombocytopenic purpura].
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Rinsho Ketsueki; 1992 Sep; 33(9):1178-82. PubMed ID: 1433939
[TBL] [Abstract][Full Text] [Related]
9. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
[TBL] [Abstract][Full Text] [Related]
10. Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment.
Cornudella Lema J; Sánchez-González B; Carrión-Barberà I; Vázquez Montes de Oca S; García Pallarols F; Salman-Monte TC
Med Clin (Barc); 2024 May; 162(10):461-469. PubMed ID: 38383267
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.
Khellaf M; Chabrol A; Mahevas M; Roudot-Thoraval F; Limal N; Languille L; Bierling P; Michel M; Godeau B
Am J Hematol; 2014 Feb; 89(2):194-8. PubMed ID: 24254965
[TBL] [Abstract][Full Text] [Related]
12. Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: Prevalence and risk factors.
Kittivisuit S; Vachvanichsanong P; McNeil E; Chotsampancharoen T
Pediatr Blood Cancer; 2021 Aug; 68(8):e29146. PubMed ID: 34047041
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with belimumab for immune thrombocytopenia associated with systemic lupus erythematosus: A report of two cases.
Nakayama K; Tamimoto Y; Nakayama T
Mod Rheumatol Case Rep; 2023 Dec; 8(1):69-73. PubMed ID: 37718578
[TBL] [Abstract][Full Text] [Related]
14. ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases.
Liu Y; Chen S; Yang G; Wang B; Lan J; Dai F; Rao P; Wu P; Qian H; Shi G
Lupus Sci Med; 2021 Oct; 8(1):. PubMed ID: 34610996
[TBL] [Abstract][Full Text] [Related]
15. Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE-related immune thrombocytopenia.
Brik-Simon D; Efros O; Levinsky Y; Amarilyo G; Tirosh I; Levy-Mendelovich S; Steinberg-Shemer O; Izraeli S; Yacobovich J; Gilad O
Pediatr Blood Cancer; 2024 May; 71(5):e30911. PubMed ID: 38348516
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study.
Liu Y; Chen S; Sun Y; Lin Q; Liao X; Zhang J; Luo J; Qian H; Duan L; Shi G
Medicine (Baltimore); 2016 Dec; 95(50):e5565. PubMed ID: 27977588
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura.
Zimmerman SA; Ware RE
J Pediatr Hematol Oncol; 1997; 19(4):297-303. PubMed ID: 9256827
[TBL] [Abstract][Full Text] [Related]
18. [Nine-year's follow up on the appearance of autoantibodies in a child with idiopathic thrombocytopenic purpura subsequently developing lupus with central nervous system manifestations].
Kagitani M; Makino S; Kinjo Y; Hirano S; Tabushi Y; Sasaki M; Takeuchi T; Hanafusa T; Murata T
Ryumachi; 2002 Jun; 42(3):591-6. PubMed ID: 12166113
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
Abe K; Ishikawa Y; Ishikawa J; Fujiwara M; Kita Y
Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytopenia subsequently develops systemic lupus erythematosus--can anti-SS-A antibody predict the next event?
Adachi M; Mita S; Obana M; Matsuoka Y; Harada K; Irimajiri S
Jpn J Med; 1990; 29(5):481-6. PubMed ID: 2089172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
